In 2017, the Kuehne + Nagel Group invested a total of CHF 225 million (2016: CHF 239 million) in fixed assets. Investments in properties and buildings amounted to CHF 48 million (2016: CHF 42 million), of which the most substantial amount into a new large-scale pharma logistics facility in Moehlin, Switzerland, and CHF 177 million (2016: CHF 197 million) were invested in other fixed assets, operating and office equipment.
All capital expenditure in 2017 was financed through operational cash flow.
In 2017, the following major investments were made in properties and buildings:
The allocation of investments in other fixed assets, operating and office equipment by category is as follows:
|Office furniture and equipment||10||11|
The allocation by region is as follows:
The allocation by business unit is as follows:
Depreciation and amortisation in 2017 amounted to CHF 213 million and was allocated in the income statement as indicated in notes 26 and 27 to the Consolidated Financial Statements.
The Group continued to operate an asset-light business model and invests only into strategically important locations with high demand for state of the art logistic space.